Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cigna Group Director's Dealing 2026

Mar 4, 2026

29918_dirs_2026-03-03_0c6ea8f9-482b-4728-a8d6-8d74459419ab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2026-02-27

Reporting Person: Neville Everett (See Remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-27 Common Stock, $.01 Par Value A 2602 Acquired 6111 Direct
2026-02-27 Common Stock, $.01 Par Value A 2678 Acquired 8789 Direct
2026-02-27 Common Stock, $.01 Par Value F 883 $287.55 Disposed 7906 Direct
2026-02-27 Common Stock, $.01 Par Value F 517 $287.55 Disposed 7389 Direct
2026-03-02 Common Stock, $.01 Par Value S 1719 $288.91 Disposed 5670 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-27 Employee Stock Option (Right to Buy) $287.5475 A 4127 Acquired 2036-02-27 Common Stock, $.01 Par Value (4127) Direct

Footnotes

F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

F2: These restricted shares vest in three equal annual installments beginning March 1, 2027.

F3: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

F4: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

F5: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2025.

F6: This option vests in three equal annual installments beginning March 1, 2027.